
Wanbury Limited has informed the Exchange regarding a press release dated September 09, 2024, titled "Press Release - Wanbury Limited received a Certificate of Suitability (CEP) forthe launch of its new product, Dextromethorphan (API)".
Filed with NSE ·

Wanbury Limited has informed the Exchange regarding a press release dated September 09, 2024, titled "Press Release - Wanbury Limited received a Certificate of Suitability (CEP) forthe launch of its new product, Dextromethorphan (API)".
6ix hasn’t read this filing yet.
Follow Wanbury into a list and get an email when it puts out news.
Follow Wanbury